Drug recall · December 7, 2016
Indiomin MB URINARY ANTISEPTIC recall
Why: CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10
- Lots / codes
LOT # 29401501, EXP 10/17
- Quantity
- 795 bottles
- Company
- Burel Pharmaceuticals Inc, Richland, MS
- Distribution
- Nationwide
- Initiated
- October 24, 2016 · Voluntary: Firm initiated
- Classified
- November 29, 2016
- Reported
- December 7, 2016
- Ended
- August 14, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hyoscyamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.